Internal Medicine, Pulmonary Disease · Somers, NY
NPI
1619940467
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
342 Route 202
Somers, NY, 10589
Phone (845) 725-0222
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,426 services
Medicare patients, 2024
427
Average age 76
Drug cost, 2024
$910K
3,668 prescriptions
Company payments, 2025
$133
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emanuel I Wurm was code 99214 (office e&m - established), 500 times for 267 patients. In total Emanuel I Wurm billed 1,426 services in 28 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 500 | 267 | $111.93 | $56K |
| 99213 Office E&M - Established | Office | 182 | 138 | $76.80 | $14K |
| 94060 Pulmonary Function Testing | Office | 109 | 104 | $30.92 | $3,370 |
| 94729 Pulmonary Function Testing | Office | 107 | 103 | $44.82 | $4,796 |
| 99232 Hospital E&M - Subsequent | Facility | 84 | 38 | $67.91 | $5,704 |
| 94726 Pulmonary Function Testing | Office | 81 | 79 | $43.61 | $3,532 |
| 99204 Office E&M - New | Office | 76 | 76 | $145.70 | $11K |
| 95012 Pulmonary | Office | 74 | 72 | $17.28 | $1,279 |
| 94727 Pulmonary Function Testing | Office | 26 | 25 | $37.34 | $971 |
| 99203 Office E&M - New | Office | 24 | 24 | $95.22 | $2,285 |
| 99222 Hospital E&M - Initial | Facility | 23 | 22 | $116.37 | $2,677 |
| 95800 Sleep Study | Office | 22 | 21 | $115.20 | $2,534 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 13 | $104.33 | $2,295 |
| 99223 Hospital E&M - Initial | Facility | 21 | 20 | $145.32 | $3,052 |
| 99441 Telephone Services | Office | 15 | 15 | $43.06 | $646 |
By year: 2022 $133K for 1,494 services; 2023 $116K for 1,332 services; 2024 $128K for 1,426 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 20 | 20 | $50.28 | $1,006 |
Medicare prescription drug claims, 2024
In 2024, the drug Emanuel I Wurm prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 707 prescriptions and refills. In total Emanuel I Wurm wrote 3,668 Medicare prescriptions that cost $910K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 707 | 939 | 256 | $20K |
| Arnuity Ellipta Fluticasone Furoate | 407 | 534 | 119 | $121K |
| Prednisone Generic | 235 | 271 | 104 | $586 |
| Advair Hfa Fluticasone Propion/Salmeterol | 225 | 321 | 49 | $116K |
| Breo Ellipta Fluticasone/Vilanterol | 189 | 322 | 54 | $124K |
| Montelukast Sodium Generic | 186 | 429 | 49 | $2,040 |
| Symbicort Budesonide/Formoterol Fumarate | 145 | 250 | 42 | $55K |
| Incruse Ellipta Umeclidinium Bromide | 140 | 184 | 27 | $63K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 133 | 167 | 29 | $107K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 121 | 181 | 41 | $15K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 109 | 153 | 28 | $25K |
| Azelastine Hcl Generic | 95 | 203 | 46 | $4,372 |
| Azithromycin Generic | 81 | 89 | 26 | $893 |
| Famotidine Generic | 81 | 166 | 26 | $887 |
| Fluticasone Propionate Generic | 68 | 130 | 32 | $1,518 |
Brand drugs: 2,108 claims; generic drugs: 1,560 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emanuel I Wurm $133 ($133 in general payments such as food, travel and fees) from 2 companies. The largest payer was Electromed, Inc. with $92.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.